Hospice Audit Series: Beyond Part D, OIG Scrutinizes the Hospice Industry to the Tune of $6.6 Billion

Husch Blackwell LLP
Contact
In a follow-up to its recent reports on billing outside the hospice benefit for drugs and durable medical equipment (DME), the Office of Inspector General’s (OIG) new data report identifies billions being billed to Medicare Part A and B for hospice patients. What lies behind the headline?

In this episode, Husch Blackwell’s Meg Pekarske, Andrew Brenton and Erin Burns unpack the OIG’s analysis and its critical shortcomings. They throw in some food for thought on what changes the industry might expect in See more +

In a follow-up to its recent reports on billing outside the hospice benefit for drugs and durable medical equipment (DME), the Office of Inspector General’s (OIG) new data report identifies billions being billed to Medicare Part A and B for hospice patients. What lies behind the headline?

In this episode, Husch Blackwell’s Meg Pekarske, Andrew Brenton and Erin Burns unpack the OIG’s analysis and its critical shortcomings. They throw in some food for thought on what changes the industry might expect in light of the growing concerns related to the unbundling of care. See less -

Embed
Copy

Other MultiMedia by Husch Blackwell LLP

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Husch Blackwell LLP | Attorney Advertising

Written by:

Husch Blackwell LLP
Contact
more
less

Husch Blackwell LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide